East Windsor, N.J. – Aurobindo Pharma Limited has launched Atazanavir Capsules 100 mg, 150 mg, 200 mg, and 300 mg upon receiving final approval from the U.S. Food and Drug Administration for its Abbreviated New Drug Application. Aurobindo’s Atazanavir Capsules are an AB-rated generic equivalent to the reference listed drug REYATAZ®. Atazanavir capsules is indicated […]
Aurobindo Launched Atazanavir Capsules Read More »
Aurobindo became a partner to Dispensary of Hope in 2012. In only 5 short years, Aurobindo has donated 3,736,413 doses of medicine. Almost 30% of these doses were donated in 2017. This is largely due to the quick and additional response to Hurricane Harvey relief efforts with additional donations. Pharmaceutical products are provided to the
Dispensary of Hope Read More »
Aurobindo has participated in Spectrum360’s annual “Fore the Kids” Golf Tournament for the past 5 years. Both as a participant and as a sponsor, Aurobindo has contributed over $20K to this organization to enable greater access and participation to children of diverse abilities. Mission Statement: “Spectrum360’s mission is to provide the highest quality educational and
East Windsor, N.J. – Aurobindo Pharma Limited has received final approval from the U.S. Food and Drug Administration for its Abbreviated New Drug Application for Sildenafil Tablets, 25mg, 50mg, and 100mg. Aurobindo’s Sildenafil Tablets are an AB-rated generic equivalent to the reference listed drug VIAGRA®. Sildenafil Citrate tablets is indicated for the treatment of erectile dysfunction.
Aurobindo Launched Sildenafil Citrate Tablets Read More »